Literature DB >> 29687215

Agreement between clinician-rated versus patient-reported outcomes in Huntington disease.

Noelle E Carlozzi1, Nicholas R Boileau2, Joel S Perlmutter3, Kelvin L Chou4, Julie C Stout5, Jane S Paulsen6,7,8, Michael K McCormack9,10, David Cella11, Martha A Nance12,13, Jin-Shei Lai11, Praveen Dayalu4.   

Abstract

BACKGROUND: Clinician-rated measures of functioning are often used as primary endpoints in clinical trials and other behavioral research in Huntington disease. As study costs for clinician-rated assessments are not always feasible, there is a question of whether patient self-report of commonly used clinician-rated measures may serve as acceptable alternatives in low risk behavioral trials. AIM: The purpose of this paper was to determine the level of agreement between self-report and clinician-ratings of commonly used functional assessment measures in Huntington disease.
DESIGN: 486 participants with premanifest or manifest Huntington disease were examined. Total Functional Capacity, Functional Assessment, and Independence Scale assessments from the Unified Huntington Disease Rating scale were completed by clinicians; a self-report version was also completed by individuals with Huntington disease. Cronbach's α was used to examine internal consistency, one-way analysis of variance was used to examine group differences, and paired t tests, kappa agreement coefficients, and intra-class correlations were calculated to determine agreement between raters.
RESULTS: Internal consistency for self-reported ratings of functional capacity and ability were good. There were significant differences between those with premanifest, early-, and late-stage disease; those with later-stage disease reported less ability and independence than the other clinical groups. Although self-report ratings were not a perfect match with associated clinician-rated measures, differences were small. Cutoffs for achieving specified levels of agreement are provided.
CONCLUSIONS: Depending on the acceptable margin of error in a study, self-reported administration of these functional assessments may be appropriate when clinician-related assessments are not feasible.

Entities:  

Keywords:  Clinician-ratings; Functioning; Huntington disease; Self-report ratings

Mesh:

Year:  2018        PMID: 29687215      PMCID: PMC5992091          DOI: 10.1007/s00415-018-8852-5

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  54 in total

1.  Poor insight into memory impairment in patients with Huntington disease.

Authors:  Emilia J Sitek; Witold Sołtan; Piotr Robowski; Michał Schinwelski; Dariusz Wieczorek; Jarosław Sławek
Journal:  Neurol Neurochir Pol       Date:  2012 Jul-Aug       Impact factor: 1.621

2.  Screening for DSM-5 Somatic Symptom Disorder: Diagnostic Accuracy of Self-Report Measures Within a Population Sample.

Authors:  Johannes A C Laferton; Nikola M Stenzel; Winfried Rief; Kristina Klaus; Elmar Brähler; Ricarda Mewes
Journal:  Psychosom Med       Date:  2017 Nov/Dec       Impact factor: 4.312

3.  Awareness of involuntary movements in Huntington disease.

Authors:  J S Snowden; D Craufurd; H L Griffiths; D Neary
Journal:  Arch Neurol       Date:  1998-06

4.  Unawareness of motor phenoconversion in Huntington disease.

Authors:  Elizabeth A McCusker; David G Gunn; Eric A Epping; Clement T Loy; Kylie Radford; Jane Griffith; James A Mills; Jeffrey D Long; Jane S Paulsen
Journal:  Neurology       Date:  2013-08-21       Impact factor: 9.910

5.  Riluzole in Huntington's disease: a 3-year, randomized controlled study.

Authors:  G Bernhard Landwehrmeyer; Bruno Dubois; Justo Garcia de Yébenes; Berry Kremer; Wilhelm Gaus; Peter H Kraus; Horst Przuntek; Michel Dib; Adam Doble; Wilhelm Fischer; Albert C Ludolph
Journal:  Ann Neurol       Date:  2007-09       Impact factor: 10.422

Review 6.  Therapeutic interventions for disease progression in Huntington's disease.

Authors:  Tiago Mestre; Joaquim Ferreira; Miguel M Coelho; Mário Rosa; Cristina Sampaio
Journal:  Cochrane Database Syst Rev       Date:  2009-07-08

7.  Fifteen Years of Clinical Trials in Huntington's Disease: A Very Low Clinical Drug Development Success Rate.

Authors:  André M Travessa; Filipe B Rodrigues; Tiago A Mestre; Joaquim J Ferreira
Journal:  J Huntingtons Dis       Date:  2017

8.  Validation of Self-reported Diagnosis of Gestational Diabetes at 6-weeks Postpartum.

Authors:  Stefanie N Hinkle; Shristi Rawal; Yeyi Zhu; Jagteshwar Grewal; Paul S Albert; Cuilin Zhang
Journal:  Epidemiology       Date:  2017-09       Impact factor: 4.822

9.  Discordance between self-reported arthritis and musculoskeletal signs and symptoms in older women.

Authors:  Tkt Lo; Lynne Parkinson; Michelle Cunich; Julie Byles
Journal:  BMC Musculoskelet Disord       Date:  2016-12-01       Impact factor: 2.362

10.  A description of sleep behaviour in healthy late pregnancy, and the accuracy of self-reports.

Authors:  Jordan P R McIntyre; Cayley M Ingham; B Lynne Hutchinson; John M D Thompson; Lesley M McCowan; Peter R Stone; Andrew G Veale; Robin Cronin; Alistair W Stewart; Kevin M Ellyett; Edwin A Mitchell
Journal:  BMC Pregnancy Childbirth       Date:  2016-05-18       Impact factor: 3.007

View more
  3 in total

1.  An App-Based Just-in-Time Adaptive Self-management Intervention for Care Partners (CareQOL): Protocol for a Pilot Trial.

Authors:  Noelle E Carlozzi; Sung Won Choi; Zhenke Wu; Jennifer A Miner; Angela K Lyden; Christopher Graves; Jitao Wang; Srijan Sen
Journal:  JMIR Res Protoc       Date:  2021-12-09

2.  Understanding How Chorea Affects Health-Related Quality of Life in Huntington Disease: An Online Survey of Patients and Caregivers in the United States.

Authors:  Eileen Mack Thorley; Ravi G Iyer; Paul Wicks; Chris Curran; Sanjay K Gandhi; Victor Abler; Karen E Anderson; Noelle E Carlozzi
Journal:  Patient       Date:  2018-10       Impact factor: 3.883

3.  Another Perspective on Huntington's Disease: Disease Burden in Family Members and Pre-Manifest HD When Compared to Genotype-Negative Participants from ENROLL-HD.

Authors:  Jannis Achenbach; Carsten Saft
Journal:  Brain Sci       Date:  2021-12-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.